Falsified Medicines Directive: responding to the engineering challenges

Published: 19-Dec-2017
Packaging Regulatory

With the deadline for the Falsified Medicines Directive looming, Shaun Baker, Managing Director of Newman Labelling Systems, answers some of the most commonly asked questions about the engineering challenges involved

You need to be a subscriber to read this article.
Click here to find out more.

Falsified medicines are fake medicines that are made to look like genuine, authorised medicines. However, they often contain little or no active ingredients, poor quality or incorrect ingredients and can have fake or tampered packaging. These medicines are a real health threat as they are not scrutinised for the usual evaluation of quality, safety and efficacy, which is legally required for sale in the EU. The Falsified Medicines Directive was introduced in July 2011 in an effort to protect patients and consumers from these counterfeit medicines. In the UK, this regulation comes into force in February 2019.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Packaging

Newman to exhibit at PPMA Show 2018

Read more
The company will exhibit one of its original benchtop label gumming machines

Trending Articles

  1. Standard proposed to clarify endotoxin testing for single-use systems The guide will address variability when assessing bacterial endotoxins on large-scale pharmaceutical equipment
  2. AlzeCure's pain project ACD440 granted orphan drug status in the US by the FDA AlzeCure Pharma announces that the US Food and Drug Administration (FDA) has granted the company's application for orphan drug status for the clinical pain candidate drug ACD440
  3. Outsourcing in pharma: a comprehensive guide to strategic advantages and considerations Outsourcing in pharma drives agility, compliance, and efficiency—NSF delivers expert audits, training, remediation, and embedded support
  4. Neopac appoints new Chief Sales Officer to strengthen global sales growth Industry veteran Bernd Steiner joins Executive Management Team, will lead international sales strategy
  5. Poolbeg granted FDA Orphan Drug Designation for POLB 001 The US FDA grants orphan status to support the development of medicines for rare disorders affecting fewer than 200,000 people in the US

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Packaging

Newman to exhibit at PPMA Show 2018

The company will exhibit one of its original benchtop label gumming machines
Packaging

Flexible and reliable tamper evident labelling solutions

Supplier of pharmaceutical labelling solutions, Newman Labelling Systems, provides two labelling solutions - the CTE350 and CTE450 - to meet Falsified Medicines Directive
Packaging

Newman Labelling demonstrates FMD compliant systems

The company will show the S350, compatible with the Track and Trace requirements of the Falsified Medicines Directive, at Interpack 2017
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Speed is of the essence. Or is it?

With ever increasing packaging production line speeds in the food and beverage sector, John Clayton, Managing Director, Newman Labelling Systems, examines why the pharmaceutical industry isn’t hurrying to follow suit
Manufacturing

High speed carton labeller with track and trace capability

The energy efficient CTE450 is versatile, compact and complies with current track and trace requirements
Packaging

Fresenius Kabi installs Newman vial labelling machine

For use at its facility in Port Elizabeth, South Africa
Packaging

Variety is the spice of life

Newman Labelling Systems has supplied an S250 automatic labelling system to Merck Animal Health to handle a range of label sizes for poultry vaccine products
Subscribe now